With several recent studies focusing on the genetic classification of DLBCL [19–22], we summarized genetic alterations that intensively or exclusively coincides with the translocation of MYC and BCL2 and/or BCL6, and characterized consequent functional disturbance. The gene discussed is MYC; the disease is diffuse large B-cell lymphoma.